Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Fundraising of £1.5 million

6 Mar 2017 07:00

RNS Number : 5468Y
Versarien PLC
06 March 2017
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW.

 

 

Versarien plc

("Versarien" or the "Company")

Successful Fundraising of £1.5 million

Versarien plc (AIM:VRS), the advanced materials group, announced on 3 March 2017 the launch of a fundraising comprising a placing by WH Ireland in conjunction with an offer via PrimaryBid (the "Offer") (together the "Fundraising") to raise approximately £1 million at 15p per new ordinary share.

The Company is delighted to announce that it has successfully completed the Fundraising. The Fundraising received a very strong response from private and institutional investors, and the Fundraising was oversubscribed. The Offer was on a "first come, first served" basis and was closed early at 7.00 p.m. on 4 March 2017, with the Fundraising having already been approximately 50% oversubscribed by that time. The Company has therefore decided to increase the size of the Fundraising in order to meet this demand. The Company will therefore issue and allot a total of 10,036,699 new ordinary shares ("New Ordinary Shares") to satisfy the Fundraising. The gross proceeds of the Fundraising are £1,505,504.85.

Henderson Global Investors and Miton, each of whom are substantial shareholders in the Company, have subscribed for 1,333,333 and 1,333,334 new ordinary shares respectively in the Fundraising. Their subscriptions constitute a related party transactions under the AIM Rules as each currently holds more than 10% of the existing ordinary shares and is therefore a "substantial shareholder" under the AIM Rules. The Directors, all of whom are independent for the purposes of this transaction, consider, having consulted with WH Ireland, the Company's nominated adviser, that the terms of Henderson's and Miton's subscriptions are fair and reasonable insofar as the Shareholders are concerned.

Application will be made to the London Stock Exchange for the New Ordinary Shares, which rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM. Dealings are expected to commence at 8.00 a.m. on 10 March 2017.

Neill Ricketts, Chief Executive Officer of Versarien, commented:

 "We are delighted with the support we have received from both existing and new institutional and private investors for the Fundraising. In particular we are delighted with the support we have received from private investors through PrimaryBid and to have the opportunity to increase the size of the Fundraising to satisfy some of that demand.

"The funds raised will allow us to significantly scale up both our graphene manufacturing capabilities and our marketing efforts to take advantage of the substantial commercial opportunities we are seeing. Versarien is at the forefront of the commercialisation of graphene and the Fundraising will allow us to more widely market our recently launched graphene brand, Nanene, and increase the resources available to the other graphene projects we are working on. We look forward to these funds allowing us to accelerate the use of graphene in a variety of commercial applications."

 

Total Voting Rights

Following the issue of the New Ordinary Shares, the Company will have 131,330,702 ordinary shares of 1p each in issue. No ordinary shares are held in treasury. The figure of 131,330,702 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Versarien plc 01242 269 122

Neil Ricketts, CEO

Chris Leigh, CFO

 

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe / Ed Allsopp

 

PrimaryBid Limited 0207 491 6519

Dave Mutton

 

IFC Advisory Ltd, Financial PR and IR 0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUVOWRBRAORAR
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.